Contego Spa Designs, Inc. v. T-Spa MFG., LLC

CourtDistrict Court, S.D. Texas
DecidedMarch 27, 2024
Docket4:23-cv-01173
StatusUnknown

This text of Contego Spa Designs, Inc. v. T-Spa MFG., LLC (Contego Spa Designs, Inc. v. T-Spa MFG., LLC) is published on Counsel Stack Legal Research, covering District Court, S.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Contego Spa Designs, Inc. v. T-Spa MFG., LLC, (S.D. Tex. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT March 27, 2024 FOR THE SOUTHERN DISTRICT OF TEXAS Nathan Ochsner, Clerk HOUSTON DIVISION

§ CONTEGO SPA DESIGNS, INC., § § Plaintiff, § v. § CIVIL ACTION NO. 23-1173 § T-SPA MFG., LLC and T-SPA DEPOT, § LLC and US NAILS SPA, INC., § § Defendants. § §

MEMORANDUM OPINION ON CLAIM CONSTRUCTION

This patent infringement suit is about chairs that nail salons use to perform pedicures. Contego Spa Designs, Inc., makes spa chairs for this purpose. The chairs include a basin in which customers soak their feet in warm water during the treatment. Water brings with it the risk of overflowing. The Contego chairs use a system of two basins to manage overflows. T-Spa Manufacturing, LLC, also makes and sells spa pedicure chairs. These chairs, sold under the name “KYEN,” also use a system of basins to catch overflowing water. Contego alleges that T-Spa’s products infringe. Contego sued T-Spa and US Nails Spa, Inc., a spa using T-Spa’s chairs, alleging infringement of its U.S. Patent No. 9,289,353 (the ‘353 Patent). (Docket Entry No. 1). Contego has since amended its complaint and dismissed US Nails Spa as a defendant. T-Spa has answered and counterclaimed. (Docket Entry No. 67). The ‘353 Patent, entitled “Pedicure Basin With Overflow Protection,” discloses Lan Van Ta as applicant and inventor, was issued on March 22, 2016, and is assigned to Contego. (Docket Entry No. 39 at ¶ 16). The ‘353 Patent claims a main basin in which a client’s feet are submerged and a second basin to catch overflow from the main basin. This main basin has at least a portion of its rim lowered to allow liquid to flow from the main basin into the second basin, without spilling the overflowing liquid onto the floor. The overflow can be accidental or intentionally done to lower the main basin water level to allow hotter or colder water to be added to change the water temperature, to maintain hygienic conditions, or to perform other tasks. During the patent

prosecution, the Ta chair was compared to a prior art spa chair, Tran, which contained a retractable basin. The inventor distinguished the prior art. The parties submitted a joint claim construction and Markman statement that identified five disputed terms in the ‘353 Patent. (Docket Entry No. 61). The parties have briefed the claim construction issues and submitted slides showing the technology at issue. (Docket Entry Nos. 68, 72, 73, 75, 76). The court held a Markman claim construction hearing on March 18, 2024, at which counsel presented argument. (Docket Entry No. 77). Based on the parties’ claim-construction briefs, counsels’ arguments, the record, and the applicable law, the court construes the five disputed terms. The constructions and the reasons for

them are set out in detail below. I. The Legal Standard for Claim Construction The “claims of a patent define the invention to which the patentee is entitled the right to exclude.” Phillips v. AWH Corp., 415 F.3d 1303, 1312 (Fed. Cir. 2005) (en banc) (quoting Innova/Pure Water, Inc. v. Safari Water Filtration Sys., Inc., 381 F.3d 1111, 1115 (Fed. Cir. 2004)). “[T]he construction of a patent, including terms of art within its claim, is exclusively within the province of the court.” Markman v. Westview Instruments, Inc., 517 U.S. 370, 372 (1996). Claim terms are “generally given their ordinary and customary meaning,” defined as “the meaning that the term would have to a person of ordinary skill in the art in question at the time of the invention.” Phillips, 415 F.3d at 1312–13 (quoting Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed. Cir. 1996)). Claim construction begins with the claim language. Aptalis Pharmatech, Inc. v. Apotex Inc., 718 Fed. App’x 965, 968 (Fed. Cir. 2018). The court looks first “to the words of the claims themselves, both asserted and nonasserted, to define the scope of the patented invention,”

Vitronics, 90 F.3d at 1582, and construes the claim terms in the context of the surrounding claim language. ACTV, Inc. v. Walt Disney Co., 346 F.3d 1082, 1088 (Fed. Cir. 2003) (“[T]he context of the surrounding words of the claim also must be considered in determining the ordinary and customary meaning of those terms.”); accord Lexion Medical, LLC v. Northgate Techs., Inc., 641 F.3d 1352, 1356 (Fed. Cir. 2011). When the words in the context of the surrounding claim language make the ordinary meaning readily apparent, claim construction “involves little more than the application of the widely accepted meaning of commonly understood words.” Phillips, 415 F.3d at 1314. If the “ordinary and customary” meaning is unclear, the court considers “the intrinsic

evidence of record, i.e., the patent itself, including the claims, the specification and, if in evidence, the prosecution history.” Vitronics, 90 F.3d at 1582. Courts review the “specification to determine whether the inventor has used any terms in a manner inconsistent with their ordinary meaning.” Id. The Federal Circuit has repeatedly stated that “claims ‘must be read in view of the specification, of which they are a part.’” Phillips, 415 F.3d at 1315 (quoting Markman v. Westview Instruments, Inc., 52 F.3d 967, 979 (Fed. Cir. 1995), aff’d, 517 U.S. 370 (1996)). The specification, a “concordance for the claims,” id. (quoting Autogiro Co. of Am. v. United States, 384 F.2d 391, 397–98 (Ct. Cl. 1967)), is the “best source for understanding a technical term,” id. (internal quotations omitted).1 “[T]he specification may reveal an intentional disclaimer, or disavowal, of claim scope by the inventor.” Id. (citing SciMed Life Sys., Inc. v. Advanced Cardiovascular Sys., Inc., 242 F.3d 1337, 1343–44 (Fed. Cir. 2001)); see also Thorner v. Sony Computer Entm’t Am. LLC, 669 F.3d 1362, 1365 (Fed. Cir. 2012) (the claim construction may deviate from the ordinary and customary meaning of a disputed term only if (1) a patentee sets out

a definition and acts as his own lexicographer, or (2) the patentee disavows the full scope of a claim term, either in the specification or during prosecution). “[A] court ‘should also consider the patent’s prosecution history, if it is in evidence.’” Phillips, 415 F.3d at 1317 (quoting Markman, 52 F.3d at 980); see also Typhoon Touch Techs., Inc. v. Dell, Inc., 659 F.3d 1376, 1381 (Fed. Cir. 2011) (“[T]he specification is the primary source for determining what was invented and what is covered by the claims, elucidated if needed by the prosecution history.”). The prosecution history “can often inform the meaning of the claim language by demonstrating how the inventor understood the invention and whether the inventor limited the invention in the course of prosecution, making the claim scope narrower than it would

otherwise be.” Phillips, 415 F.3d at 1317 (citing Vitronics, 90 F.3d at 1582–83). The prosecution history includes “all express representations made by or on behalf of the applicant to the examiner to induce a patent grant, or . . . to reissue a patent . . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Titan Tire Corp. v. Case New Holland, Inc.
566 F.3d 1372 (Federal Circuit, 2009)
Andersen Corp. v. Fiber Composites, LLC
474 F.3d 1361 (Federal Circuit, 2007)
Lexion Medical, LLC v. Northgate Technologies, Inc.
641 F.3d 1352 (Federal Circuit, 2011)
Autogiro Company of America v. The United States
384 F.2d 391 (Court of Claims, 1967)
Orthokinetics, Inc. v. Safety Travel Chairs, Inc.
806 F.2d 1565 (Federal Circuit, 1986)
Biodex Corporation v. Loredan Biomedical, Inc.
946 F.2d 850 (Federal Circuit, 1991)
Zircon Corp. v. Stanley Black & Decker, Inc.
452 F. App'x 966 (Federal Circuit, 2011)
Thorner v. Sony Computer Entertainment America LLC
669 F.3d 1362 (Federal Circuit, 2012)
Sanofi-Aventis Deutschland & GMBH v. Genentech, Inc.
473 F. App'x 885 (Federal Circuit, 2012)
Southwall Technologies, Inc. v. Cardinal Ig Company
54 F.3d 1570 (Federal Circuit, 1995)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
Contego Spa Designs, Inc. v. T-Spa MFG., LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/contego-spa-designs-inc-v-t-spa-mfg-llc-txsd-2024.